DiabetesHealth – Inhaled Insulin to Treat Diabetes Earns FDA Committee Recommendation

The drug, an inhaled powder, completed phase III testing in August of 2013. If approved, it will be the first ultra rapid-acting mealtime insulin therapy available in the United States. Read more



from DiabetesNews http://ift.tt/1nk0v2o